Remo Moomiaie-Qajar

Dr. Moomiaie-Qajar has served as Cytonus’ Chief Executive Officer since our inception, having successfully led the spin-out of Cytonus from University of California San Diego (UCSD) in 2018 to change the paradigm of disease using Cytonus’ platform of Bio-Drone therapeutics called Cargocytes. He is a trained surgeon from Yale University with a long history of developing innovative technologies in medicine and transforming them into commercially-viable products. Remo holds multiple US and international patents, and has 15 years of experience incubating technologies from venture-stage to exit. Dr. Moomiaie-Qajar’s background as an academic researcher, physician, and entrepreneur brings a unique trifecta of perspective and experience to Cytonus.